Filing Details
- Accession Number:
- 0001104659-24-039193
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-26 20:08:11
- Reporting Period:
- 2024-03-25
- Accepted Time:
- 2024-03-26 20:08:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124524 | Cryoport Inc. | CYRX | Pharmaceutical Preparations (2834) | 880313393 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848218 | W Mark Sawicki | C/O Cryoport Inc. 112 Westwood Place, Suite 350 Brentwood TN 37027 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-03-25 | 1,367 | $17.54 | 77,444 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
Billionaire Hedge Funds
